These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4553276)

  • 1. [In-vitro exchange of 42 K between plasma and erythrocytes in the course of ascitic liver cirrhosis].
    Afifi F; Boivin P; Fauvert R
    Pathol Biol (Paris); 1972 Feb; 20(3):159-64. PubMed ID: 4553276
    [No Abstract]   [Full Text] [Related]  

  • 2. ["In vitro" exchange of radioactive sodium (Na22) between plasma and erythrocytes cirrhotic patients].
    Afifi F; Boivin P; Fauvert R
    Pathol Biol (Paris); 1969; 17(15):733-8. PubMed ID: 4907906
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of diuretic treatment on red cell and plasma sodium concentration in patients with hepatic cirrhosis and ascites.
    Afifi F
    Biomedicine; 1975 Feb; 23(2):68-72. PubMed ID: 1156631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.
    Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C
    Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some red blood cell abnormalities in patients with liver cirrhosis and ascites. I. Red blood cell sodium, potassium and water content.
    Afifi F
    Tohoku J Exp Med; 1985 Jan; 145(1):7-14. PubMed ID: 3983958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell sodium and potassium contents in liver cirrhosis.
    Astrup J; Prytz H; Thomsen AC; Westrup M
    Gastroenterology; 1980 Mar; 78(3):530-4. PubMed ID: 7351291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrolyte metabolism anomalies in liver cirrhosis].
    Okumura M; Katsuki S
    Saishin Igaku; 1968 Dec; 23(12):2527-33. PubMed ID: 4889816
    [No Abstract]   [Full Text] [Related]  

  • 8. Red blood cell sodium and potassium concentrations in patients with liver diseases.
    Liang YK; Hwang SY; Fong MS; Schaeffer BT; Feng TT; Cheng TC
    Southeast Asian J Trop Med Public Health; 1972 Sep; 3(3):411-8. PubMed ID: 4347069
    [No Abstract]   [Full Text] [Related]  

  • 9. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell content of water, sodium and potassium in body fluid disturbances.
    Czaczkes JW; Aviram A; Keynan A; Ullmann TD
    Isr J Med Sci; 1967; 3(1):137-42. PubMed ID: 6030416
    [No Abstract]   [Full Text] [Related]  

  • 11. [Water and electrolyte distribution in the erythrocytes of normal subjects and cirrhotic patients].
    Afifi F; Boivin P; Fauvert R
    Pathol Biol; 1968 Oct; 16(19):847-51. PubMed ID: 4881630
    [No Abstract]   [Full Text] [Related]  

  • 12. [Water and salt metabolism in the hepatopathic patient, with special reference to hypokalemia].
    Santagostino A
    G Gerontol; 1972 Jun; 20(6):535-41. PubMed ID: 5046893
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significances of plasma levels of neuropeptide Y pre- and post-treatment in patients with decompensated cirrhosis and ascites].
    Li GW; Wu LD; Zhu Y
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):483-4. PubMed ID: 12754138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal dialysis in hyponatremia due to liver failure.
    Ring-Larsen H; Clausen E; Ranek L
    Scand J Gastroenterol; 1973; 8(1):33-40. PubMed ID: 4697064
    [No Abstract]   [Full Text] [Related]  

  • 16. [Disorders of water-electrolyte balance in chronic hepatitis and liver cirrhosis].
    Dederer IuM; Rozhkova TA
    Ter Arkh; 1975; 47(2):72-8. PubMed ID: 1145463
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S; Bellati G; Ideo G
    Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide.
    Chen YX; Wang SC; Zhao GN; Tang J; Zhang SX; Tang CS
    Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of atrial natriuretic factor on renal excretion of sodium in patients with liver cirrhosis].
    Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1994; 18(6-7):568-73. PubMed ID: 7875416
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathogenesis and treatment of the edema-ascites syndrome in patients with cirrhosis of the liver].
    Loginov AS; Berezov VM
    Ter Arkh; 1967 Aug; 39(8):12-20. PubMed ID: 4890954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.